Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001140361-11-036680
Filing Date
2011-07-13
Accepted
2011-07-13 15:56:29
Documents
1
Effectiveness Date
2011-07-13
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9607
  Complete submission text file 0001140361-11-036680.txt   10660
Mailing Address 755 Research Parkway Suite 435 Oklahoma City OK 73104
Business Address 755 Research Parkway Suite 435 Oklahoma City OK 73104 (405) 319-8177
Altheus Therapeutics Inc (Filer) CIK: 0001414163 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D/A | Act: 33 | File No.: 021-109372 | Film No.: 11965911